|
New treatment for diabetes.(Updates)
FDA Consumer
|
January 1, 2007
|
COPYRIGHT 2007 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
The FDA has approved Januvia (sitagliptin phosphate) tablets, the first diabetes treatment approved in a new class of drugs, DPP-IV inhibitors, that enhances the body's own ability to lower elevated blood sugar.
Januvia was approved in October 2006 to improve blood sugar levels in people with type 2 diabetes. Januvia can be used alone or in combination with two other commonly prescribed oral diabetes medications, metformin or a peroxisome proliferator-activated receptor gamma (PPAR) agonist, when either of these drugs alone, along with diet and exercise, doesn't provide ...
Find more facts and information related to the
article "New treatment for diabetes.(Updates)"